24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825

Mental Disorders
Resources
Basic InformationLookupsLatest News
Taking Your Meds? A Digital Pill Can TellFDA OKs First 'Digital Pill' That Lets Doctors Know It's Been TakenIs Too Much Time Online Raising Suicide Risk in Teen Girls?Childhood Spanking Could Heighten Adult Mental Health WoesSurgical Residents Prime Candidates for Stress, Depression, Alcohol AbuseMedical License Questions Sway Doctors' Mental Health HelpAmericans More Open About Mental Health Issues, But Stigma LingersNarrow Networks in ACA Marketplace for Mental HealthHurricanes' Toll on Mental Health Will LingerER Visits for These 3 Health Woes Don't Have to HappenPreventive Psychological, Educational Programs BeneficialPsychosocial Intervention App Feasible in Serious Mental IllnessHealth Tip: Mental Disorders Are CommonNearly 1 in 5 U.S. Adults Has Mental Illness or Drug ProblemHalf of Opioid Prescriptions Go to People With Mental IllnessPsychological Risks Higher in Atopic Dermatitis PatientsSAMHSA: 9.8 Million U.S. Adults Have Serious Mental IllnessNearly 10 Million U.S. Adults Suffer From Mental IllnessSuicide Risk Is High for Psychiatric Patients Long After Discharge From CareStreptococcal Throat Infection Linked to Mental DisordersMental Health Myths Abound in the U.S.Care Access Worsening for Adults With Psychological DistressJust 1 in 5 Mentally Ill Women Gets Cervical Cancer ScreeningsAnxious? Distressed? You're Not AlonePast Psychiatric Disorders Do Not Raise Risk of Alzheimer's DiseasePast Psychiatric Ills Don't Raise Alzheimer's Risk: StudySelf-Harm Can Be a Harbinger of SuicideClimate Change May Cloud Americans' Mental Health: ReportKetamine Beneficial for Certain Patients With Mood DisordersPatients Reluctant to Comply With Drug-Only Psychiatric TreatmentPatients Often Reject Drug-Only Psychiatric TreatmentStudy Links Psychiatric Disorders to Stroke RiskAnxiety, Depression May Up Mortality Risk for Some CancersMental Health May Affect Chances Against CancerObamacare Covered More People With Mental Illness, AddictionsMany With Mental Illness Miss Out on HIV TestsMortality Risk in T2DM Increased With Depression and/or AnxietyMost Smokers With Mental Illness Want to Kick the HabitU.S. Soldier in Custody Following Slaying of 5 Americans in Iraq
Questions and AnswersLinks
Related Topics

Anxiety Disorders
Bipolar Disorder
Depression: Depression & Related Conditions
Schizophrenia
Eating Disorders

Ketamine Beneficial for Certain Patients With Mood Disorders


HealthDay News
Updated: Mar 8th 2017

new article illustration

WEDNESDAY, March 8, 2017 (HealthDay News) -- Use of ketamine for treatment of mood disorders should include appropriate patient selection and consideration of potential risks of treatment, according to a consensus statement published online March 1 in JAMA Psychiatry.

Gerard Sanacora, M.D., Ph.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues examined data on the use of ketamine for mood disorder treatment.

The researchers note that ketamine may be helpful for some patients with mood disorders. Appropriate patient section should include diagnostic considerations, with the strongest evidence supporting ketamine's benefit in treatment of major depressive disorder without psychotic features, as well as assessment of other medical, psychological, and social factors. Most studies supporting ketamine's benefit assessed efficacy during the first week following a single infusion; emerging studies indicate that repeated dosing may extend the efficacy for at least several weeks. However, the available data are limited and potential risks associated with ketamine should be considered before its use.

"The suggestions provided are intended to facilitate clinical decision making and encourage an evidence-based approach to using ketamine in the treatment of psychiatric disorders considering the limited information that is currently available," the authors write. "This article provides information on potentially important issues related to the off-label treatment approach that should be considered to help ensure patient safety."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)